home / stock / biib / biib articles

BIIB Articles, Biogen Inc. - From 12/29/23

Stock Information
Company Name: Biogen Inc.
Stock Symbol: BIIB
Market: NASDAQ
Website: biogen.com
Menu
BIIB BIIB Quote BIIB Short BIIB News BIIB Articles BIIB Message Board
Get BIIB Alerts

News, Short Squeeze, Breakout and More Instantly...
Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024 | Benzinga

According to the Global Data report, the pharma sector in Q3 2023 witnessed deals worth $28 billion, down 28% from the $54 billion recorded in Q2 2...
Understanding Biogen's Position In Biotechnology Industry Compared To Competitors | Benzinga

In the dynamic and cutthroat world of business, conducting thorough company analysis is essential for investors and industry experts. In this artic...

If You Invested $100 In This Stock 20 Years Ago, You Would Have $800 Today | Benzinga

Biogen (NASDAQ:BIIB) has outperformed the market over the past 20 years by 3.19% on an annualized basis producing an average annual return of 10.72...

$1000 Invested In This Stock 20 Years Ago Would Be Worth $7,200 Today | Benzinga

Biogen (NASDAQ:BIIB) has outperformed the market over the past 20 years by 2.89% on an annualized basis producing an average annual return of 10.34...
S&P 500's Hidden Gems: 27 Stocks With 30%+ Upside Potential According To Wall Street Analysts Targets | Benzinga

The S&P 500 Index has risen by 19% year-to-date, with three weeks remaining in the year and just a five percentage point gap from the all-time ...

Comparative Study: Biogen And Industry Competitors In Biotechnology Industry | Benzinga

In today's rapidly changing and highly competitive business world, it is imperative for investors and industry observers to carefully assess c...

Alzheimer's Disease Vaccines: Promising Developments, Renewed Enthusiasm From Biogen, Eli Lilly And Others | Benzinga

Recent advancements in Alzheimer's disease treatments targeting the removal of toxic proteins (white matter) from the brain have sparked a rene...
Here's How Much $1000 Invested In Biogen 20 Years Ago Would Be Worth Today | Benzinga

Biogen (NASDAQ:BIIB) has outperformed the market over the past 20 years by 2.35% on an annualized basis producing an average annual return of 9.84%...

Industry Comparison: Evaluating Biogen Against Competitors In Biotechnology Industry | Benzinga

In today's rapidly evolving and fiercely competitive business landscape, it is crucial for investors and industry analysts to conduct comprehe...

These Analysts Revise Their Forecasts On Biogen After Q3 Results | Benzinga

Biogen Inc (NASDAQ: BIIB) reported better-than-expected third-quarter earnings. Biogen posted quarterly sales of $2.53 billion, beating the consen...
Previous 10 Next 10